Myriad Genetics Ownership | Who Owns Myriad Genetics?

Overview Forecast RevenueFinancials Chart Transcripts

Myriad Genetics Ownership Summary

Myriad Genetics is owned by 14.25% institutional investors, 2.82% insiders, and 82.94% retail investors. Blackrock is the largest institutional shareholder, holding 18.54% of MYGN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.89% of its assets in Myriad Genetics shares.

MYGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Myriad Genetics	14.25%	2.82%	82.94%
Sector	Healthcare Stocks	232.51%	10.72%	-143.22%
Industry	Diagnostics & Research Stocks	35.38%	11.00%	53.62%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	15.15M	18.54%	$370.59M
Blackrock funding, inc. /de	15.30M	16.44%	$94.12M
Vanguard group	8.23M	8.84%	$50.59M
State street	4.98M	5.38%	$35.98M
Glenview capital management	4.59M	4.96%	$33.17M
Millennium management	4.35M	4.78%	$59.57M
Morgan stanley	3.61M	3.88%	$22.19M
Bank of america corp /de/	2.71M	3.31%	$66.18M
Geode capital management	2.23M	2.40%	$13.73M
Goldman sachs group	2.16M	2.32%	$13.29M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Amh equity	400.00K	3.60%	$2.89M
Camber capital management lp	2.00M	1.00%	$10.62M
Glenview capital management	4.59M	0.74%	$33.17M
Anson funds management lp	504.38K	0.33%	$3.65M
Vestal point capital, lp	600.00K	0.20%	$4.34M
Algert global	913.07K	0.11%	$6.60M
Gsa capital partners llp	187.82K	0.10%	$1.16M
Aimz investment advisors	39.19K	0.09%	$283.31K
Inspire investing	79.69K	0.06%	$576.13K
Vise	11.65K	0.05%	$284.98K

Top Buyers

Holder	Shares	% Assets	Change
Algert global	913.07K	0.11%	913.07K
D. e. shaw	1.82M	0.02%	668.43K
Vestal point capital, lp	600.00K	0.20%	600.00K
Point72 asset management	1.07M	0.01%	535.90K
Nuveen	1.19M	0.00%	465.67K

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	-	-	-4.59M
Earnest partners	-	-	-3.98M
Sei investments	-	-	-2.42M
Artisan partners limited partnership	-	-	-2.28M
Loomis sayles & co l p	-	-	-2.19M

New Positions

Holder	Shares	% Assets	Change	Value
Vestal point capital, lp	600.00K	0.20%	600.00K	$4.34M
Weiss asset management lp	130.34K	0.01%	130.34K	$942.38K
Massachusetts financial services co /ma/	117.44K	0.00%	117.44K	$722.23K
Martingale asset management l p	74.02K	0.01%	74.02K	$535.19M
Isam funds (uk)	31.65K	0.05%	31.65K	$228.85K

Sold Out

Holder	Change
Cnb bank	-1.00
Global financial private client	-3.00
Jfs wealth advisors	-3.00
Mendota financial group	-3.00
Mather group, llc.	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	63	-71.49%	13,263,036	-85.02%	14	0.16%	30	-74.36%	21	-70.42%
Sep 30, 2025	79	-62.74%	17,328,183	-77.55%	18	0.27%	39	-69.29%	25	-52.83%
Jun 30, 2025	218	-5.63%	90,330,011	-3.80%	97	0.92%	130	8.33%	52	-32.47%
Mar 31, 2025	230	3.60%	93,858,128	1.60%	103	1.00%	119	-1.65%	77	4.05%
Dec 31, 2024	205	-17.00%	86,534,887	-4.62%	95	0.77%	111	-15.91%	70	-1.41%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	5.48M	5.89%	-
Vanguard Explorer Inv	3.10M	3.40%	-190.91K
Vanguard US Total Market Shares ETF	2.70M	2.96%	2.75K
Vanguard Total Stock Mkt Idx Inv	2.66M	2.85%	-58.92K
iShares Russell 2000 ETF	2.19M	2.35%	-
Artisan Non-U.S. Small-Mid Growth Comp	1.56M	1.70%	-281.57K
Artisan International Small-Mid Investor	1.56M	1.70%	-281.57K
EARNEST Partners Smid Cap Core Founders	1.40M	1.52%	-970.66K
SPDR® S&P Biotech ETF	1.38M	1.48%	3.08K
Vanguard Small Cap Index	1.06M	1.14%	-7.19K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 11, 2024	DIAZ PAUL J	President and CEO	Sell	$343.95K
Sep 11, 2024	DIAZ PAUL J	President and CEO	Sell	$400.80K
Sep 11, 2024	Muzzey Dale	Chief Scientific Officer	Sell	$54.96K
Sep 09, 2024	Dreismann Heinrich	-	Sell	$270.52K
Sep 03, 2024	Reitan Colleen F	-	Sell	$1.29M

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-

MYGN Ownership FAQ

Who Owns Myriad Genetics?

Myriad Genetics shareholders are primarily institutional investors at 14.25%, followed by 2.82% insiders and 82.93% retail investors. The average institutional ownership in Myriad Genetics's industry, Diagnostics & Research Stocks, is 35.38%, which Myriad Genetics falls below.

Who owns the most shares of Myriad Genetics?

Myriad Genetics’s largest shareholders are Blackrock (15.15M shares, 18.54%), Blackrock funding, inc. /de (15.3M shares, 16.44%), and Vanguard group (8.23M shares, 8.84%). Together, they hold 43.81% of Myriad Genetics’s total shares outstanding.

Does Blackrock own Myriad Genetics?

Yes, BlackRock owns 18.54% of Myriad Genetics, totaling 15.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 370.59M$. In the last quarter, BlackRock increased its holdings by 271.49K shares, a 1.82% change.

Who is Myriad Genetics’s biggest shareholder by percentage of total assets invested?

Amh equity is Myriad Genetics’s biggest shareholder by percentage of total assets invested, with 3.60% of its assets in 400K Myriad Genetics shares, valued at 2.89M$.

Who is the top mutual fund holder of Myriad Genetics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Myriad Genetics shares, with 5.89% of its total shares outstanding invested in 5.48M Myriad Genetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools